Cargando…

The Cost-Effectiveness of Low-Cost Essential Antihypertensive Medicines for Hypertension Control in China: A Modelling Study

BACKGROUND: Hypertension is China’s leading cardiovascular disease risk factor. Improved hypertension control in China would result in result in enormous health gains in the world’s largest population. A computer simulation model projected the cost-effectiveness of hypertension treatment in Chinese...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gu, Dongfeng, He, Jiang, Coxson, Pamela G., Rasmussen, Petra W., Huang, Chen, Thanataveerat, Anusorn, Tzong, Keane Y., Xiong, Juyang, Wang, Miao, Zhao, Dong, Goldman, Lee, Moran, Andrew E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4524696/ https://www.ncbi.nlm.nih.gov/pubmed/26241895 http://dx.doi.org/10.1371/journal.pmed.1001860

Ejemplares similares

Antihypertensive Prescribing for Uncomplicated, Incident Hypertension: Opportunities for Cost Savings
por: Quinn, Amity E., et al.
Publicado: (2021)

Cost-effectiveness analysis of nebivolol and metoprolol in essential hypertension: A pharmacoeconomic comparison of antihypertensive efficacy of beta blockers
por: Patel, Rachna S., et al.
Publicado: (2014)

Cost-effectiveness Analyses of Antihypertensive Medicines: A Systematic Review
por: Park, Chanhyun, et al.
Publicado: (2017)

Young Adult Exposure to Cardiovascular Risk Factors and Risk of Events Later in Life: The Framingham Offspring Study
por: Pletcher, Mark J., et al.
Publicado: (2016)

Non-adherence to antihypertensive medications in Lebanese adults hospitalized for hypertensive urgency and its cost
por: Abbas, Hanine, et al.
Publicado: (2022)

A cost-minimization analysis of diuretic-based antihypertensive therapy reducing cardiovascular events in older adults with isolated systolic hypertension
por: Chen, G John, et al.
Publicado: (2005)

Utilization, Cost, and Affordability of Antihypertensive Therapy in Bulgaria
por: Mitkova, Zornitsa, et al.
Publicado: (2021)

Is Yangxue Qingnao Granule Combined with Antihypertensive Drugs, a New Integrative Medicine Therapy, More Effective Than Antihypertensive Therapy Alone in Treating Essential Hypertension?
por: Wang, Jie, et al.
Publicado: (2013)

Cost-effectiveness of digital therapeutics for essential hypertension
por: Nomura, Akihiro, et al.
Publicado: (2022)

The future impact of population growth and aging on coronary heart disease in China: projections from the Coronary Heart Disease Policy Model-China
por: Moran, Andrew, et al.
Publicado: (2008)

Cost-effectiveness analysis of guidelines for antihypertensive care in Finland
por: Booth, Neill, et al.
Publicado: (2007)

Antihypertensive and Antioxidant Action of Amlodipine and Vitamin C in Patients of Essential Hypertension
por: Mahajan, Aarti S., et al.
Publicado: (2007)

Cost-utility analysis of antihypertensive medications in Nigeria: a decision analysis
por: Ekwunife, Obinna Ikechukwu, et al.
Publicado: (2013)

Physician adherence to hypertension treatment guidelines and drug acquisition costs of antihypertensive drugs at the cardiac clinic: a pilot study
por: Abdulameer, Shaymaa Abdalwahed, et al.
Publicado: (2012)

Estimation of cost-based prices for injectable medicines in the WHO Essential Medicines List
por: Gotham, Dzintars, et al.
Publicado: (2019)

Cost-Related Antihypertensive Medication Nonadherence: Action in the Time of COVID-19 and Beyond
por: Tajeu, Gabriel S, et al.
Publicado: (2020)

The Cost-Effectiveness of an Intervention Program to Enhance Adherence to Antihypertensive Medication in Comparison With Usual Care in Community Pharmacies
por: Bosmans, Judith E., et al.
Publicado: (2019)

Renal vascular response to angiotensin II inhibition in intensive antihypertensive treatment of essential hypertension
por: Lubas, Arkadiusz, et al.
Publicado: (2010)

Effects of four different antihypertensive drugs on plasma metabolomic profiles in patients with essential hypertension
por: Hiltunen, Timo P., et al.
Publicado: (2017)

Human essential hypertension: no significant association of polygenic risk scores with antihypertensive drug responses
por: Sánez Tähtisalo, Heini, et al.
Publicado: (2020)

Adherence to antihypertensive fixed-dose combination among Egyptian patients presenting with essential hypertension
por: Hassanein, Mahmoud
Publicado: (2020)

Effects of nebivolol versus other antihypertensive drugs on the endothelial dysfunction in patients with essential hypertension
por: Li, Bingwei, et al.
Publicado: (2020)

Network Meta-Analysis of the Antihypertensive Effect of Traditional Chinese Exercises on Patients with Essential Hypertension
por: Li, Lingling, et al.
Publicado: (2022)

Design and study protocol for a cluster randomized trial of a multi-faceted implementation strategy to increase the uptake of the USPSTF hypertension screening recommendations: the EMBRACE study
por: Moise, Nathalie, et al.
Publicado: (2020)

Antihypertensive Effect of Long-Term Monotherapy with Esaxerenone in Patients with Essential Hypertension: Relationship Between Baseline Urinary Sodium Excretion and Its Antihypertensive Effect
por: Ichikawa, Shuichi, et al.
Publicado: (2022)

Estimated costs of production and potential prices for the WHO Essential Medicines List
por: Hill, Andrew M, et al.
Publicado: (2018)

Blood pressure reduction, persistence and costs in the evaluation of antihypertensive drug treatment – a review
por: Bramlage, Peter, et al.
Publicado: (2009)

The potential savings of using thiazides as the first choice antihypertensive drug: cost-minimisation analysis
por: Fretheim, Atle, et al.
Publicado: (2003)

Chinese Patent Medicine Liu Wei Di Huang Wan Combined with Antihypertensive Drugs, a New Integrative Medicine Therapy, for the Treatment of Essential Hypertension: A Systematic Review of Randomized Controlled Trials
por: Wang, Jie, et al.
Publicado: (2012)

Essential Medicines for Dental Caries: Cost-Effectiveness of ART and SDF: Julia Gierth
por: Gierth, J, et al.
Publicado: (2022)

The effect of Taohong Siwu decoction combined with antihypertensive medicine in the treatment of hypertension: Meta-analysis
por: Xie, Peng-Cheng, et al.
Publicado: (2022)

Antihypertensive therapy among newly treated patients: An analysis of adherence and cost of treatment over years
por: Esposti, Luca Degli, et al.
Publicado: (2010)

Choice of generic antihypertensive drugs for the primary prevention of cardiovascular disease - A cost-effectiveness analysis
por: Wisløff, Torbjørn, et al.
Publicado: (2012)

Projected Impact of Salt Restriction on Prevention of Cardiovascular Disease in China: A Modeling Study
por: Wang, Miao, et al.
Publicado: (2016)

Costs of Safe Medicine
por: Kerr, D.N.S.
Publicado: (1980)

Predictors of uncontrolled hypertension and antihypertensive medication nonadherence
por: Morgado, Manuel, et al.
Publicado: (2010)

Preventing the Progression of Prehypertension to Hypertension: Role of Antihypertensives
por: Fuchs, Flávio Danni, et al.
Publicado: (2014)

Adherence to Antihypertensive Medication in Older Adults With Hypertension
por: Lo, Suzanne H. S., et al.
Publicado: (2016)

Antihypertensive Medicines Prescriptions before and after the Nigeria Hypertension Society Guidelines and Prescriber's Awareness of the Guideline
por: Olowofela, Abimbola, et al.
Publicado: (2017)

Simultaneous Use of Herbal Medicines and Antihypertensive Drugs Among Hypertensive Patients in the Community: A Review
por: Azizah, Nur, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3li4hb2hs13s1s59nt67mgh310